4 - 6 June, 2024
Excel London Platinum Suite Werner MeierChief Scientific Officer at Revitope OncologySpeaker
Profile
Revitope Oncology: Chief Scientific Officer and acting CEO Biogen: Vice President of Biologics Drug Discovery, responsible for developing therapeutic protein drug candidates. Program Executive of two development programs aimed at treating immunologic and neurological diseases Applied BioMath and Institute for Protein Innovation: Scientific board member
Agenda Sessions
Progress on REV403, A Guided Antibody T cell Engager Targeting EGFR and PDL1 for Solid Tumors
, 11:00View Session